Neuropsychological correlates of amyloid precursor protein in alzheimer's disease

International Journal of Nursing Practice

Volumn 2, Issue 1, 1996, Pages 29-32

  Thomas, Linda D ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Alzheimer's disease; Amyloid precursor protein; Neuropsychological correlates.

Indexed keywords

AMYLOID PRECURSOR PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD; COGNITIVE DEFECT; FEMALE; HUMAN; MALE; MASS SCREENING; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGICAL ASPECT;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; COGNITION DISORDERS; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS;

EID: 0030089921     PISSN: 13227114     EISSN: 1440172X     Source Type: Journal    
DOI: 10.1111/j.1440-172X.1996.tb00018.x     Document Type: Article

References (14)

1. Pike CJ, Burdick D, Walencewicz AJ, Glabe CG, Colman CW. Neurodegeneration induced by beta-amyloid peptides in vitro: The role of peptide assembly state. journal .f Neuroscience 1993; 13: 1676-1687.
2. Cacabelos R, Fernandez Novoa L, Perez Trullen JM, Franco Maside A. Serum histamine in Alzheimer's disease and multiinfarct dementia. Metbods and Findings Experimental Clinical Pharmacology 1992; 14: 71 1-715.
3. Murphy M. The molecular pathogenesis of Alzheimer's disease: Clinical prospects. The Lancet 1992; 340: 1512-1515.
4. Bush AI, Whyte S , Thomas LD et al. An abnormality of plasma amyloid protein precursor in Alzheimer's disease. Annals $Neurology 1992; 32: 57-65.
5. Bush AI, Beyreuther K, Masters CL. Beta A4 amyloid protein and its precursor in Alzheimer's disease. Pharmacology Therapeutics 1992; 56: 97-1 17.
6. Roth M, Tym E, Mountjoy CQ, Huppert FA. CAMDEX: A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. British journal $Psychiatry 1986; 149: 698-709.
7. Folstein M, Folstein S, McHugh PR. Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician.journa1 ofpsychiatric Research 1975; 12: 189-198.
8. Hodkinson HM. Evaluation of a mental test score for assessment of mental impairment in the elderly. Age and Ageing 1972; 1: 233-238.
9. Jorm AF, Scott R, Jacomb PA. Assessment of cognitive decline in dementia by informant questionnaire. International Journal of Geriatric Psychiatry 1989; 4: 35-39.
10. McKhann G, Drachrnan D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: Report of NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984; 34: 939-944.
11. Weidemann A, Konig G, Bunke D et al. Identification, biogenesis, and localisation of precursors of Alzheimer's disease A4 amyloid protein. Cell 1989; 57: 1 15-1 26.
12. Lindeboom J, Ter Horst R, Hooyer C, Dinkgreve M, Jonker C. Some psychometric properties of the CAMCOG. Psychological Medicine 1993; 23: 213-219.
13. Jorm AF, Scott R, Cullen JS, MacKinnon AJ. Performance of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) as a screening test for dementia. Psychological Medicine 1991 ; 21 : 785-790.
14. Terry RD, Masliah E, Salmon DP et al. Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the correlate of cognitive impairment. Annals Neurology 1991 ; 30: 572-580.